Development of a more thermostable poliovirus vaccine

Journal of Infectious Diseases

Volumn 175, Issue 2 SUPPL., 1997, Pages

  Milstien, Julie B ^a   Lemon, Stanley M ^a   Wright, Peter F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEUTERIUM OXIDE; ORAL POLIOMYELITIS VACCINE; STABILIZING AGENT; WATER;

CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG SAFETY; DRUG STABILITY; FOOD AND DRUG ADMINISTRATION; HUMAN; INFANT; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; THERMOSTABILITY; VACCINE PRODUCTION; WORLD HEALTH ORGANIZATION;

EID: 0031020387     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.supplement_1.s247     Document Type: Review

References (5)

1. Galazka A. Stability of vaccines. Geneva: World Health Organization, 1989; publication no. WHO/EPI/GEN/89.8.
2. 2-stabilized oral poliovaccine. JAMA 1961;185:406-8.
3. Global Advisory Group, Expanded Programme on Immunization. Report of the 15th Global Advisory Group. Geneva: World Health Organization, 1992; publication no. WHO/EPI/GEN/92.
4. Hull HF, Ward NA, Hull BP, Milstien JB, de Quadros C. Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet 1994;343:1331-7.
5. Lemon SM, Milstien JB. The thermostability of vaccines. Technologies for improving the thermostability of the oral poliovirus vaccine. Int J Technol Assess Health Care 1994;10:177-84.